Poul-Erik Braad

University of Southern Denmark

Denmark

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Thomas Lund Andersen

DENMARK

View details

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Birgitte Nørgaard

University of Southern Denmark

DENMARK

View details

Oke Gerke

Professor in Clinical Biostatistics in Diagnostic Research

University of Southern Denmark

DENMARK

View details

Mads Hvid Poulsen

Associate Professor

University of Southern Denmark

DENMARK

View details

Malene G. Hildebrandt

DENMARK

View details

Marianne Vogsen

Odense University Hospital

DENMARK

View details

Peter Thye-Rønn

University of Southern Denmark

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Poul-Erik Braad

Research Interests

Explore related searches

Contact this professor

Articles (10)

A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol

2-[<sup>18</sup>F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.

Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer.

Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT

Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

FDG-PET/CT in high-risk primary breast cancer

Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer

Collaborators (8)

Thomas Lund Andersen

Annette Raskov Kodahl

Birgitte Nørgaard

Oke Gerke

Mads Hvid Poulsen

Malene G. Hildebrandt

Marianne Vogsen

Peter Thye-Rønn

Make your next move.